• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症:诊断时的主要特征:向更轻微形式的趋势。

Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms.

机构信息

Medizinische Klinik und Poliklinik IV, Klinikum der Universität, LMU München, München, Germany.

Department of Nephrology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

出版信息

Eur J Endocrinol. 2018 Jun;178(6):605-611. doi: 10.1530/EJE-17-0978. Epub 2018 Apr 10.

DOI:10.1530/EJE-17-0978
PMID:29636356
Abstract

OBJECTIVE

Primary aldosteronism (PA) is the most common endocrine form of arterial hypertension. The German Conn's Registry's purpose is to improve treatment outcomes of PA. We assessed whether key clinical, biochemical and epidemiological characteristics of newly diagnosed PA cases have changed over time, potentially indicating a different screening and referral practice in Germany evolving from 2008 to 2016.

DESIGN

The German Conn's Registry is a multicenter database prospectively analyzing morbidity and long-term outcome of patients with PA.

METHODS

Phenotypic changes between three year periods were calculated using Mann-Whitney tests and Kruskal-Wallis tests for independent variables.

RESULTS

Over three time periods from 2008 to 2016, we noted a relative decrease of unilateral PA cases (67 vs 43%). Significantly more females were diagnosed with PA (33 vs 43%). Median daily defined drug doses decreased (3.1 vs 2.0) in the presence of unchanged SBP (150 vs 150 mmHg), plasma aldosterone (199 vs 173 ng/L) and PRC (3.2 vs 3.2 U/L). Median ARR values decreased (70 vs 47 ng/U) and median potassium levels at diagnosis (3.5 vs 3.7 mmol/L) increased as the percentage of normokalemic patients (25 vs 41%), indicating milder forms of PA.

CONCLUSIONS

Our results are in accordance with an increased screening intensity for PA. We identified a trend toward diagnosing milder forms, increasingly more females and less unilateral cases of PA.

摘要

目的

原醛症(PA)是最常见的内分泌性高血压。德国康恩氏登记处的目的是改善 PA 的治疗效果。我们评估了新诊断的 PA 病例的关键临床、生化和流行病学特征是否随时间发生变化,这可能表明德国的筛查和转诊实践有所不同,从 2008 年到 2016 年有所演变。

设计

德国康恩氏登记处是一个多中心数据库,前瞻性分析 PA 患者的发病率和长期预后。

方法

使用 Mann-Whitney U 检验和 Kruskal-Wallis 检验计算三年期间的表型变化。

结果

在 2008 年至 2016 年的三个时间段中,我们注意到单侧 PA 病例的相对减少(67 例对 43%)。诊断为 PA 的女性明显增多(33%对 43%)。在收缩压(150 对 150mmHg)、血浆醛固酮(199 对 173ng/L)和 PRC(3.2 对 3.2U/L)不变的情况下,每日定义药物剂量中位数降低(3.1 对 2.0)。ARR 值中位数(70 对 47ng/U)降低,诊断时血钾中位数(3.5 对 3.7mmol/L)升高,正常血钾患者的比例(25%对 41%)升高,提示 PA 表现形式较轻。

结论

我们的结果与 PA 筛查强度增加一致。我们发现诊断出的 PA 形式较轻、女性患者增多、单侧病例减少的趋势。

相似文献

1
Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms.原发性醛固酮增多症:诊断时的主要特征:向更轻微形式的趋势。
Eur J Endocrinol. 2018 Jun;178(6):605-611. doi: 10.1530/EJE-17-0978. Epub 2018 Apr 10.
2
Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.盐水输注试验后醛固酮水平可反映原发性醛固酮增多症的严重程度和结局。
Eur J Endocrinol. 2015 Apr;172(4):443-50. doi: 10.1530/EJE-14-1013. Epub 2015 Jan 28.
3
Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.醛固酮和肾素浓度与炎症的关联——波美拉尼亚健康研究及德国原发性醛固酮增多症登记研究
Endocrine. 2017 Aug;57(2):298-307. doi: 10.1007/s12020-017-1348-8. Epub 2017 Jun 22.
4
Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry.分析特性会影响醛固酮与肾素比值作为原发性醛固酮增多症的筛查工具:德国 Conn 登记研究的结果。
Horm Metab Res. 2013 Jul;45(7):526-31. doi: 10.1055/s-0033-1343448. Epub 2013 Apr 23.
5
Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry.原发性醛固酮增多症与糖尿病有关吗?德国康恩登记处的结果。
Horm Metab Res. 2010 Jun;42(6):435-9. doi: 10.1055/s-0029-1246189. Epub 2010 Jan 29.
6
Normokalemic hyperaldosteronism in patients with resistant hypertension.顽固性高血压患者的正常血钾性醛固酮增多症
Isr Med Assoc J. 2002 Jan;4(1):17-20.
7
The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism.醛固酮/肾素比值可预测无经典原发性醛固酮增多症患者的心血管代谢紊乱。
Am J Hypertens. 2019 Apr 22;32(5):468-475. doi: 10.1093/ajh/hpz023.
8
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.原发性醛固酮增多症患者中心血管疾病及其危险因素的流行情况:日本多中心研究。
Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22.
9
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry.德国 Conn 登记处原发性醛固酮增多症患者中糖尿病和代谢综合征的患病率增加。
Eur J Endocrinol. 2015 Nov;173(5):665-75. doi: 10.1530/EJE-15-0450. Epub 2015 Aug 26.
10
Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism - Findings From the German Conn's Registry.原发性醛固酮增多症患者的原发性和继发性甲状旁腺功能亢进——来自德国Conn登记处的研究结果
Exp Clin Endocrinol Diabetes. 2020 Apr;128(4):246-254. doi: 10.1055/a-1027-6472. Epub 2019 Nov 7.

引用本文的文献

1
Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights.原发性醛固酮增多症的范式转变:通过整合病理生理学见解重新考虑筛查策略
Front Endocrinol (Lausanne). 2025 Jan 14;15:1372683. doi: 10.3389/fendo.2024.1372683. eCollection 2024.
2
Historical changes in the clinical features of primary aldosteronism.原发性醛固酮增多症临床特征的历史变迁
Hypertens Res. 2024 Oct;47(10):2926-2929. doi: 10.1038/s41440-024-01819-z. Epub 2024 Aug 8.
3
Clinical characteristics of primary aldosteronism screened from Chinese patients with hypertension: The China primary aldosteronism prospective study.
从中国高血压患者中筛选出的原发性醛固酮增多症的临床特征:中国原发性醛固酮增多症前瞻性研究。
J Clin Hypertens (Greenwich). 2024 Sep;26(9):1082-1089. doi: 10.1111/jch.14874. Epub 2024 Jul 22.
4
Targeted Treatment Reverses Increased Left Cardiac Work in Unilateral vs. Bilateral Primary Aldosteronism.单侧与双侧原发性醛固酮增多症患者的靶向治疗逆转左心工作量增加。
Am J Hypertens. 2024 Oct 14;37(11):884-892. doi: 10.1093/ajh/hpae087.
5
Clinical and imaging presentations are associated with function in incidental adrenocortical adenomas: a retrospective cohort study.偶然发现的肾上腺皮质腺瘤的临床和影像学表现与功能相关:一项回顾性队列研究。
Eur J Endocrinol. 2024 Jul 2;191(1):47-54. doi: 10.1093/ejendo/lvae078.
6
Temporal trends in clinical features of patients with primary aldosteronism over 20 years.原发性醛固酮增多症患者 20 年临床特征的时间趋势。
Hypertens Res. 2024 Aug;47(8):2019-2028. doi: 10.1038/s41440-024-01703-w. Epub 2024 May 17.
7
Bilateral or Unilateral Aldosterone Hypersecretion and Responsiveness to Therapy Are Associated with Differences in Calcium/Phosphate Homeostasis in Patients with Primary Aldosteronism.双侧或单侧醛固酮分泌过多及对治疗的反应与原发性醛固酮增多症患者钙/磷稳态的差异相关。
Intern Med. 2024 Oct 1;63(19):2605-2612. doi: 10.2169/internalmedicine.3116-23. Epub 2024 Feb 26.
8
Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register.是否必须进行肾上腺静脉采样以区分单侧和双侧原发性醛固酮增多症?来自 SPAIN-ALDO 登记处的教训。
Endocrine. 2024 May;84(2):683-693. doi: 10.1007/s12020-023-03609-y. Epub 2023 Nov 27.
9
2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism.2023 韩国内分泌学会原发性醛固酮增多症诊断与管理共识指南。
Endocrinol Metab (Seoul). 2023 Dec;38(6):597-618. doi: 10.3803/EnM.2023.1789. Epub 2023 Oct 13.
10
Biomarkers to Guide Medical Therapy in Primary Aldosteronism.用于指导原发性醛固酮增多症的医学治疗的生物标志物。
Endocr Rev. 2024 Jan 4;45(1):69-94. doi: 10.1210/endrev/bnad024.